Press enter to see results or esc to cancel.

Endodiag

Riding the wave: Endodiag is part of the global femtech industry, which is expected to grow at a CAGR of 13% from 2021 to 2026.

Continue Reading

Kheiron Medical Technologies

Kheiron Medical is on a mission to help breast cancer patients live longer, better lives through earlier detection. Its solution, called Mia (Mammography Intelligent Assessment), combines new deep learning methods, data science, and radiology insights to help doctors find malignancies in mammograms. Whilst many AI technologies are not designed to be inclusive, Kheiron’s technology has …

Continue Reading

Mindpeak

MindPeak builds automation tools for visual diagnosis using state-of-the-art artificial intelligence and deep learning. Its tools assist cancer experts in providing reliable and reproducible diagnoses. This frees specialists from tedious, repetitive tasks such as the quantification of cells or biomarkers and allows them to focus on tasks where their human expertise is indispensable. The company …

Continue Reading

Elypta

Elypta is a molecular diagnostics company focused on reducing cancer mortality through early detection. Elypta is pioneering a metabolism-based liquid biopsy and measures the GAGome, which are system biomarkers of tumor metabolism. Machine learning algorithms are then used to detect signatures of cancer non-invasively. Elypta is advancing a broad clinical program across different cancers, with …

Continue Reading

Ultromics

Born at the University of Oxford, Ultromics provides autonomous echocardiography analysis through its AI solutions, empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. The company’s cloud-based services, EchoGo and EchoGo Pro, fully automates the pathway to diagnosis of coronary artery disease, heart failure and amyloidosis — providing near-instant reports for clinicians without …

Continue Reading

Methinks

Methinks has developed medical imaging software that detects cerebral artery occlusions and hemorrhages using artificial intelligence without the need for a CT scan with contrast. The company’s tech reduces time-to-treatment, enabling radiologists to communicate with hospitals, stroke units, and healthcare professionals. While Methinks is currently focusing on strokes, the second cause of death and a …

Continue Reading

EarlySight

EarlySight aims to reduce vision loss by enabling efficient detection and better monitoring of eye diseases. The company develops a high-performance eye imaging instrument in the form of a unique ophthalmic camera, empowering doctors to see the first disease impacts. Its technology allows visualizing the morphology of many cells in the retina that are playing …

Continue Reading